Oncogenic inflammation and autoimmune disease
- 31 December 2006
- journal article
- review article
- Published by Elsevier BV in Autoimmunity Reviews
- Vol. 6 (2), 107-114
- https://doi.org/10.1016/j.autrev.2006.04.002
Abstract
Many models exist to explain the induction and perpetuation of autoimmune diseases. Despite their validation in a variety of animal models, the basis for autoimmune disease in humans remains unknown. Here, we propose that an important aspect of autoimmune disease is the active participation of the target organ due to endogenously produced co-stimulatory factors that cause prolonged antigen presentation and lymphocyte activation. Evidence suggests that a major source of such endogenous signaling comes from newly transformed cells within the target organ that produce pro-inflammatory factors.Keywords
This publication has 35 references indexed in Scilit:
- Stress cytokines: pivotal proteins in immune regulatory networksCurrent Opinion in Immunology, 2004
- Human Pancreatic Islet-Derived Progenitor Cell Engraftment in Immunocompetent MiceThe American Journal of Pathology, 2004
- CD25 expression on donor CD4+ or CD8+ T cells is associated with an increased risk for graft-versus-host disease after HLA-identical stem cell transplantation in humansBlood, 2004
- Inflammation and cancerNature, 2002
- ret/PTC-1 Activation in Hashimoto ThyroiditisInternational Journal of Surgical Pathology, 2000
- Viral Clearance Without Destruction of Infected Cells During Acute HBV InfectionScience, 1999
- Positional cloning of the APECED geneNature Genetics, 1997
- Expression of the RET/PTC Fusion Gene as a Marker for Papillary Carcinoma in Hashimoto's ThyroiditisThe Laryngoscope, 1997
- Rheumatoid arthritis: how well do the theories fit the evidence?Clinical and Experimental Immunology, 1993
- Ablation of “tolerance” and induction of diabetes by virus infection in viral antigen transgenic miceCell, 1991